tiprankstipranks
Advertisement
Advertisement

DE:RFM Stock Latest News

Buy Rating on Sensorion SAS Driven by First-Mover GJB2 Gene Therapy SENS-601 and Strong Preclinical Proof-of-Concept
RatingsBuy Rating on Sensorion SAS Driven by First-Mover GJB2 Gene Therapy SENS-601 and Strong Preclinical Proof-of-Concept
2M ago
Sensorion: Differentiated OTOF and GJB2 Gene Therapy Pipeline Positions Company for Best-in-Class Outcomes and Attractive Risk-Reward Into 2026
PremiumRatings
Sensorion: Differentiated OTOF and GJB2 Gene Therapy Pipeline Positions Company for Best-in-Class Outcomes and Attractive Risk-Reward Into 2026
3M ago
Strong Buy Recommendation for Sensorion SAS Amid Promising Audiogene Study Results and Strategic Growth Prospects
PremiumRatings
Strong Buy Recommendation for Sensorion SAS Amid Promising Audiogene Study Results and Strategic Growth Prospects
4M ago
Strategic Positioning of Sensorion SAS in the Gene Therapy Market for Hearing Loss
PremiumRatings
Strategic Positioning of Sensorion SAS in the Gene Therapy Market for Hearing Loss
6M ago
Sensorion SAS: Promising Prospects in Hearing Loss Gene Therapy Justify Buy Rating
PremiumRatings
Sensorion SAS: Promising Prospects in Hearing Loss Gene Therapy Justify Buy Rating
6M ago
Promising Progress in Sensorion SAS’s Gene Therapy Trials Drives Buy Rating
PremiumRatingsPromising Progress in Sensorion SAS’s Gene Therapy Trials Drives Buy Rating
9M ago
Promising Early Data from Sensorion’s SENS-501 Study Supports Buy Rating
Premium
Ratings
Promising Early Data from Sensorion’s SENS-501 Study Supports Buy Rating
9M ago
Optimistic Buy Rating for Sensorion SAS Amid Promising Gene Therapy Developments
Premium
Ratings
Optimistic Buy Rating for Sensorion SAS Amid Promising Gene Therapy Developments
9M ago
Sensorion SAS: Promising Growth Potential and Financial Stability Justify Buy Rating
PremiumRatings
Sensorion SAS: Promising Growth Potential and Financial Stability Justify Buy Rating
1y ago
Sensorion SAS: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
PremiumRatings
Sensorion SAS: Strong Financial Position and Promising Clinical Progress Justify Buy Rating
1y ago
Promising Clinical Developments and Commercial Potential Drive Buy Rating for Sensorion SAS
PremiumRatings
Promising Clinical Developments and Commercial Potential Drive Buy Rating for Sensorion SAS
1y ago
Positive Outlook on Sensorion’s Gene Therapy Initiatives Bolstered by Promising Study Results
PremiumRatings
Positive Outlook on Sensorion’s Gene Therapy Initiatives Bolstered by Promising Study Results
1y ago
Positive Outlook for Sensorion SAS: Progress in SENS-501 and Audiogene Studies Boosts Buy Rating
PremiumRatingsPositive Outlook for Sensorion SAS: Progress in SENS-501 and Audiogene Studies Boosts Buy Rating
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >